Selected research
Industry Growth & Trends
Global Contraceptive Devices Industry Growth and Trends Forecast to 2032
Market perspective
The global Contraceptive Devices market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The North America market for Contraceptive Devices is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.
The Europe market for Contraceptive Devices is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Contraceptive Devices is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Contraceptive Devices include Actavis, Agile Therapeutics, Ansell, Caya, Church & Dwight, Condomi Health, HLL Lifecare, Karex Industries and Medicines360, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report provides a structured, data-driven view of the global Contraceptive Devices market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The Contraceptive Devices market size, estimates, and forecasts are presented in terms of sales volume (W Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Contraceptive Devices market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Contraceptive Devices.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading manufacturers in the global Contraceptive Devices market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
Contraceptive Devices Market by Company
Actavis
Agile Therapeutics
Ansell
Caya
Church & Dwight
Condomi Health
HLL Lifecare
Karex Industries
Medicines360
Okamoto Industries
The Female Health Company
TodaySponge
Bayer
Merck & Co
Teva Pharmaceutical
Contraceptive Devices Segment by Type
Male Contraceptive Devices
Female Contraceptive Devices
Contraceptive Devices Segment by Application
E-Commerce
Retail Pharmacy
Online Pharmacy
Hospital Pharmacy
Others
Contraceptive Devices Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Contraceptive Devices market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Contraceptive Devices and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Contraceptive Devices.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Contraceptive Devices manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Sales, revenue of Contraceptive Devices in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.
Chapter 13: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Male Contraceptive Devices
- Female Contraceptive Devices
Applications
- E-Commerce
- Retail Pharmacy
- Online Pharmacy
- Hospital Pharmacy
- Others
Companies covered
- Actavis
- Agile Therapeutics
- Ansell
- Caya
- Church & Dwight
- Condomi Health
- HLL Lifecare
- Karex Industries
- Medicines360
- Okamoto Industries
- The Female Health Company
- TodaySponge
- Bayer
- Merck & Co
- Teva Pharmaceutical
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.2.1 Global Contraceptive Devices Market Size Estimates and Forecasts (2021-2032)
- 1.2.2 Global Contraceptive Devices Sales Estimates and Forecasts (2021-2032)
- 1.3 Contraceptive Devices Market by Type
- 1.3.1 Male Contraceptive Devices
- 1.3.2 Female Contraceptive Devices
- 1.4 Global Contraceptive Devices Market Size by Type
- 1.4.1 Global Contraceptive Devices Market Size Overview by Type (2021-2032)
- 1.4.2 Global Contraceptive Devices Historic Market Size Review by Type (2021-2026)
- 1.4.3 Global Contraceptive Devices Forecasted Market Size by Type (2027-2032)
- 1.5 Key Regions Market Size by Type
- 1.5.1 North America Contraceptive Devices Sales Breakdown by Type (2021-2026)
- 1.5.2 Europe Contraceptive Devices Sales Breakdown by Type (2021-2026)
- 1.5.3 Asia-Pacific Contraceptive Devices Sales Breakdown by Type (2021-2026)
- 1.5.4 South America Contraceptive Devices Sales Breakdown by Type (2021-2026)
- 1.5.5 Middle East and Africa Contraceptive Devices Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
- 2.1 Contraceptive Devices Industry Trends
- 2.2 Contraceptive Devices Industry Drivers
- 2.3 Contraceptive Devices Industry Opportunities and Challenges
- 2.4 Contraceptive Devices Industry Restraints
3 Market Competitive Landscape by Company
- 3.1 Global Top Players by Contraceptive Devices Revenue (2021-2026)
- 3.2 Global Top Players by Contraceptive Devices Sales (2021-2026)
- 3.3 Global Top Players by Contraceptive Devices Price (2021-2026)
- 3.4 Global Contraceptive Devices Industry Company Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Contraceptive Devices Major Company Production Sites & Headquarters
- 3.6 Global Contraceptive Devices Company, Product Type & Application
- 3.7 Global Contraceptive Devices Company Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Contraceptive Devices Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Contraceptive Devices Players Market Share by Revenue in 2025
- 3.8.3 2025 Contraceptive Devices Tier 1, Tier 2, and Tier 3
4 Contraceptive Devices Regional Status and Outlook
- 4.1 Global Contraceptive Devices Market Size and CAGR by Region: 2021 VS 2025 VS 2032
- 4.2 Global Contraceptive Devices Historic Market Size by Region
- 4.2.1 Global Contraceptive Devices Sales in Volume by Region (2021-2026)
- 4.2.2 Global Contraceptive Devices Sales in Value by Region (2021-2026)
- 4.2.3 Global Contraceptive Devices Sales (Volume & Value), Price and Gross Margin (2021-2026)
- 4.3 Global Contraceptive Devices Forecasted Market Size by Region
- 4.3.1 Global Contraceptive Devices Sales in Volume by Region (2027-2032)
- 4.3.2 Global Contraceptive Devices Sales in Value by Region (2027-2032)
- 4.3.3 Global Contraceptive Devices Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Contraceptive Devices by Application
- 5.1 Contraceptive Devices Market by Application
- 5.1.1 E-Commerce
- 5.1.2 Retail Pharmacy
- 5.1.3 Online Pharmacy
- 5.1.4 Hospital Pharmacy
- 5.1.5 Others
- 5.2 Global Contraceptive Devices Market Size by Application
- 5.2.1 Global Contraceptive Devices Market Size Overview by Application (2021-2032)
- 5.2.2 Global Contraceptive Devices Historic Market Size Review by Application (2021-2026)
- 5.2.3 Global Contraceptive Devices Forecasted Market Size by Application (2027-2032)
- 5.3 Key Regions Market Size by Application
- 5.3.1 North America Contraceptive Devices Sales Breakdown by Application (2021-2026)
- 5.3.2 Europe Contraceptive Devices Sales Breakdown by Application (2021-2026)
- 5.3.3 Asia-Pacific Contraceptive Devices Sales Breakdown by Application (2021-2026)
- 5.3.4 South America Contraceptive Devices Sales Breakdown by Application (2021-2026)
- 5.3.5 Middle East and Africa Contraceptive Devices Sales Breakdown by Application (2021-2026)
6 Company Profiles
- 6.1 Actavis
- 6.1.1 Actavis Company Information
- 6.1.2 Actavis Business Overview
- 6.1.3 Actavis Contraceptive Devices Sales, Revenue and Gross Margin (2021-2026)
- 6.1.4 Actavis Contraceptive Devices Product Portfolio
- 6.1.5 Actavis Recent Developments
- 6.2 Agile Therapeutics
- 6.2.1 Agile Therapeutics Company Information
- 6.2.2 Agile Therapeutics Business Overview
- 6.2.3 Agile Therapeutics Contraceptive Devices Sales, Revenue and Gross Margin (2021-2026)
- 6.2.4 Agile Therapeutics Contraceptive Devices Product Portfolio
- 6.2.5 Agile Therapeutics Recent Developments
- 6.3 Ansell
- 6.3.1 Ansell Company Information
- 6.3.2 Ansell Business Overview
- 6.3.3 Ansell Contraceptive Devices Sales, Revenue and Gross Margin (2021-2026)
- 6.3.4 Ansell Contraceptive Devices Product Portfolio
- 6.3.5 Ansell Recent Developments
- 6.4 Caya
- 6.4.1 Caya Company Information
- 6.4.2 Caya Business Overview
- 6.4.3 Caya Contraceptive Devices Sales, Revenue and Gross Margin (2021-2026)
- 6.4.4 Caya Contraceptive Devices Product Portfolio
- 6.4.5 Caya Recent Developments
- 6.5 Church & Dwight
- 6.5.1 Church & Dwight Company Information
- 6.5.2 Church & Dwight Business Overview
- 6.5.3 Church & Dwight Contraceptive Devices Sales, Revenue and Gross Margin (2021-2026)
- 6.5.4 Church & Dwight Contraceptive Devices Product Portfolio
- 6.5.5 Church & Dwight Recent Developments
- 6.6 Condomi Health
- 6.6.1 Condomi Health Company Information
- 6.6.2 Condomi Health Business Overview
- 6.6.3 Condomi Health Contraceptive Devices Sales, Revenue and Gross Margin (2021-2026)
- 6.6.4 Condomi Health Contraceptive Devices Product Portfolio
- 6.6.5 Condomi Health Recent Developments
- 6.7 HLL Lifecare
- 6.7.1 HLL Lifecare Company Information
- 6.7.2 HLL Lifecare Business Overview
- 6.7.3 HLL Lifecare Contraceptive Devices Sales, Revenue and Gross Margin (2021-2026)
- 6.7.4 HLL Lifecare Contraceptive Devices Product Portfolio
- 6.7.5 HLL Lifecare Recent Developments
- 6.8 Karex Industries
- 6.8.1 Karex Industries Company Information
- 6.8.2 Karex Industries Business Overview
- 6.8.3 Karex Industries Contraceptive Devices Sales, Revenue and Gross Margin (2021-2026)
- 6.8.4 Karex Industries Contraceptive Devices Product Portfolio
- 6.8.5 Karex Industries Recent Developments
- 6.9 Medicines360
- 6.9.1 Medicines360 Company Information
- 6.9.2 Medicines360 Business Overview
- 6.9.3 Medicines360 Contraceptive Devices Sales, Revenue and Gross Margin (2021-2026)
- 6.9.4 Medicines360 Contraceptive Devices Product Portfolio
- 6.9.5 Medicines360 Recent Developments
- 6.10 Okamoto Industries
- 6.10.1 Okamoto Industries Company Information
- 6.10.2 Okamoto Industries Business Overview
- 6.10.3 Okamoto Industries Contraceptive Devices Sales, Revenue and Gross Margin (2021-2026)
- 6.10.4 Okamoto Industries Contraceptive Devices Product Portfolio
- 6.10.5 Okamoto Industries Recent Developments
- 6.11 The Female Health Company
- 6.11.1 The Female Health Company Company Information
- 6.11.2 The Female Health Company Business Overview
- 6.11.3 The Female Health Company Contraceptive Devices Sales, Revenue and Gross Margin (2021-2026)
- 6.11.4 The Female Health Company Contraceptive Devices Product Portfolio
- 6.11.5 The Female Health Company Recent Developments
- 6.12 TodaySponge
- 6.12.1 TodaySponge Company Information
- 6.12.2 TodaySponge Business Overview
- 6.12.3 TodaySponge Contraceptive Devices Sales, Revenue and Gross Margin (2021-2026)
- 6.12.4 TodaySponge Contraceptive Devices Product Portfolio
- 6.12.5 TodaySponge Recent Developments
- 6.13 Bayer
- 6.13.1 Bayer Company Information
- 6.13.2 Bayer Business Overview
- 6.13.3 Bayer Contraceptive Devices Sales, Revenue and Gross Margin (2021-2026)
- 6.13.4 Bayer Contraceptive Devices Product Portfolio
- 6.13.5 Bayer Recent Developments
- 6.14 Merck & Co
- 6.14.1 Merck & Co Company Information
- 6.14.2 Merck & Co Business Overview
- 6.14.3 Merck & Co Contraceptive Devices Sales, Revenue and Gross Margin (2021-2026)
- 6.14.4 Merck & Co Contraceptive Devices Product Portfolio
- 6.14.5 Merck & Co Recent Developments
- 6.15 Teva Pharmaceutical
- 6.15.1 Teva Pharmaceutical Company Information
- 6.15.2 Teva Pharmaceutical Business Overview
- 6.15.3 Teva Pharmaceutical Contraceptive Devices Sales, Revenue and Gross Margin (2021-2026)
- 6.15.4 Teva Pharmaceutical Contraceptive Devices Product Portfolio
- 6.15.5 Teva Pharmaceutical Recent Developments
7 North America by Country
- 7.1 North America Contraceptive Devices Sales by Country
- 7.1.1 North America Contraceptive Devices Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.1.2 North America Contraceptive Devices Sales by Country (2021-2026)
- 7.1.3 North America Contraceptive Devices Sales Forecast by Country (2027-2032)
- 7.2 North America Contraceptive Devices Market Size by Country
- 7.2.1 North America Contraceptive Devices Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2.2 North America Contraceptive Devices Market Size by Country (2021-2026)
- 7.2.3 North America Contraceptive Devices Market Size Forecast by Country (2027-2032)
8 Europe by Country
- 8.1 Europe Contraceptive Devices Sales by Country
- 8.1.1 Europe Contraceptive Devices Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.1.2 Europe Contraceptive Devices Sales by Country (2021-2026)
- 8.1.3 Europe Contraceptive Devices Sales Forecast by Country (2027-2032)
- 8.2 Europe Contraceptive Devices Market Size by Country
- 8.2.1 Europe Contraceptive Devices Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2.2 Europe Contraceptive Devices Market Size by Country (2021-2026)
- 8.2.3 Europe Contraceptive Devices Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
- 9.1 Asia-Pacific Contraceptive Devices Sales by Country
- 9.1.1 Asia-Pacific Contraceptive Devices Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.1.2 Asia-Pacific Contraceptive Devices Sales by Country (2021-2026)
- 9.1.3 Asia-Pacific Contraceptive Devices Sales Forecast by Country (2027-2032)
- 9.2 Asia-Pacific Contraceptive Devices Market Size by Country
- 9.2.1 Asia-Pacific Contraceptive Devices Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2.2 Asia-Pacific Contraceptive Devices Market Size by Country (2021-2026)
- 9.2.3 Asia-Pacific Contraceptive Devices Market Size Forecast by Country (2027-2032)
10 South America by Country
- 10.1 South America Contraceptive Devices Sales by Country
- 10.1.1 South America Contraceptive Devices Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.1.2 South America Contraceptive Devices Sales by Country (2021-2026)
- 10.1.3 South America Contraceptive Devices Sales Forecast by Country (2027-2032)
- 10.2 South America Contraceptive Devices Market Size by Country
- 10.2.1 South America Contraceptive Devices Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2.2 South America Contraceptive Devices Market Size by Country (2021-2026)
- 10.2.3 South America Contraceptive Devices Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
- 11.1 Middle East and Africa Contraceptive Devices Sales by Country
- 11.1.1 Middle East and Africa Contraceptive Devices Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.1.2 Middle East and Africa Contraceptive Devices Sales by Country (2021-2026)
- 11.1.3 Middle East and Africa Contraceptive Devices Sales Forecast by Country (2027-2032)
- 11.2 Middle East and Africa Contraceptive Devices Market Size by Country
- 11.2.1 Middle East and Africa Contraceptive Devices Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2.2 Middle East and Africa Contraceptive Devices Market Size by Country (2021-2026)
- 11.2.3 Middle East and Africa Contraceptive Devices Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
- 12.1 Contraceptive Devices Value Chain Analysis
- 12.1.1 Contraceptive Devices Key Raw Materials
- 12.1.2 Key Raw Materials Price
- 12.1.3 Raw Materials Key Suppliers
- 12.1.4 Manufacturing Cost Structure
- 12.1.5 Contraceptive Devices Production Mode & Process
- 12.2 Contraceptive Devices Sales Channels Analysis
- 12.2.1 Direct Comparison with Distribution Share
- 12.2.2 Contraceptive Devices Distributors
- 12.2.3 Contraceptive Devices Customers
13 Concluding Insights
14 Appendix
- 14.1 Reasons for Doing This Study
- 14.2 Research Methodology
- 14.3 Research Process
- 14.4 Authors List of This Report
- 14.5 Data Source
- 14.5.1 Secondary Sources
- 14.5.2 Primary Sources
- 14.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst